About Neena Bitritto-Garg
Neena Bitritto-Garg is a founder and chief executive officer, director at Ensho Therapeutics.
Neena Bitritto-Garg first appears on SEC filings in 2024.
Experience
This experience comes from Neena Bitritto-Garg's profile and from SEC filings. For roles taken from filings, the years are when the filings name Neena Bitritto-Garg in the role, so the role may have started earlier or lasted longer.
Ensho Therapeutics, Inc.
Founder and Chief Executive Officer, director
Founder, Board Director (2024 – 2026)
2024 – 2026 · Woodcliff Lake, NJ
Develops oral medicines for people with inflammatory diseases.
DB
Deutsche Bank
Biopharma Equity Research Lead
2023 – 2024
CI
Citi
Head of US Biotech Equity Research
2012 – 2023
JC
JPMorgan Chase & Co.
Large-Cap Biotech Equity Research Associate
2019
EU
Eisai US
Associate Director, Alliance Management, Dementia-Total Inclusive Ecosystem
2018 – 2019
BA
Baird
Senior Equity Research Associate, Large-Cap Biotech
2015 – 2018
CH
Cello Health
Senior Research Analyst
2014 – 2015
TP
The Children's Hospital of Philadelphia
Student Researcher
2012 – 2013
IC
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
Research Intern, Bioprocess Sciences
2011
NA
NJ Meadowlands Business Accelerator
Intern, Business Development
2009
PB
Prospect Biosystems
Research Intern
2007 – 2008
MI
Menssana Research Inc
Research Intern
2006
Key Colleagues at Startups
The people Neena Bitritto-Garg works with at each company, as listed on that company's latest Form D.
Ensho Therapeutics, Inc. · Form D, Oct 15, 2026
DF
Danielle Fry
Chief Operating Officer and Chief Legal Officer
AR
Arash Rassoulpour
Director
CS
Carlos Solorzano
Director
EP
Eric Pham
Director
Gerhard Hagn
Chief Executive Officer and director
TK
Tariq Kassum
Director